78.7%
2025 (latest)
HPV ≥1 DOSE, FEMALES AGED 13–17 YEARS
percent · 2006–2025 · higher is better · CDC NIS-Teen (TeenVaxView), National Immunization Survey
1.0%
2006
79.1%
high · 2024
1.0%
low · 2006
+78 pts
since 2006
≥1 dose, girlsup to date, all teensup-to-date is a stricter measure, defined in 2016
┊ dashed lines mark 2008 Global financial crisis · 2020 COVID-19 pandemic
Method & caveats. CDC NIS-Teen survey-year share of females aged 13–17 years receiving at least one HPV dose. Paired with teenHpvUtd, which uses both a different dose definition (up-to-date) and different sex scope (males and females); these are not one continuous series.
Sources
Every value on this page is read from the publisher below. Current and historical source documents:
- https://data.cdc.gov/resource/ee48-w5t6.json
- https://github.com/danielmiessler/substrate/tree/main/Data/US-Disease-And-Vaccination
Data
| Year | HPV ≥1 dose, females aged 13–17 years | HPV up-to-date, males and females aged 13–17 years | Change |
|---|---|---|---|
| 2025 | 78.7% | 63.4% | −0.4 pts |
| 2024 | 79.1% | 62.9% | +0.6 pts |
| 2023 | 78.5% | 61.4% | +0.7 pts |
| 2022 | 77.8% | 62.6% | −0.7 pts |
| 2021 | 78.5% | 61.7% | +1.4 pts |
| 2020 | 77.1% | 58.6% | +3.9 pts |
| 2019 | 73.2% | 54.2% | +3.3 pts |
| 2018 | 69.9% | 51.1% | +1.3 pts |
| 2017 | 68.6% | 48.6% | +3.5 pts |
| 2016 | 65.1% | 43.4% | +2.3 pts |
| 2015 | 62.8% | — | +2.8 pts |
| 2014 | 60.0% | — | +2.7 pts |
| 2013 | 57.3% | — | +3.5 pts |
| 2012 | 53.8% | — | +0.8 pts |
| 2011 | 53.0% | — | +4.3 pts |
| 2010 | 48.7% | — | +4.4 pts |
| 2009 | 44.3% | — | +7.1 pts |
| 2008 | 37.2% | — | +12 pts |
| 2007 | 25.1% | — | +24 pts |
| 2006 | 1.0% | — | — |
Also in Disease & Vaccination